Of note is that Clock is directly regulated by REV-ERBα [45] and therefore agonists for REV-ERBα [4] may not only reduce Fabp7 expression but also Clock levels, which may reduce neurogenesis and lower the potential of glioblastoma development. This evidence concerns the gene FABP7 and glioblastoma.